We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Qualys
QLYS
$6.35B
| $9.36M | 0.02% |
128,685
+112,214
| +681% | +$7.74M |
|
452
Zebra Technologies
ZBRA
$17.8B
| $9.24M | 0.02% |
66,414
-10,686
| -14% | -$1.37M |
|
453
McGrath RentCorp
MGRC
$2.92B
| $9.18M | 0.02% |
170,923
-6,511
| -4% | -$325K |
|
|
PX
454
DELISTED
Praxair Inc
PX
| $9.04M | 0.02% |
62,631
-483,675
| -89% | -$75.2M |
|
455
OraSure Technologies
OSUR
$279M
| $8.91M | 0.02% |
527,595
+125,523
| +31% | +$2.38M |
|
|
PNK
456
DELISTED
Pinnacle Entertainment Inc.
PNK
| $8.9M | 0.02% |
295,056
-161,629
| -35% | -$5.06M |
|
|
BWP
457
DELISTED
Boardwalk Pipeline Partners
BWP
| $8.88M | 0.02% |
875,171
+772,250
| +750% | +$9.16M |
|
458
Marcus & Millichap
MMI
$1.19B
| $8.87M | 0.02% |
246,073
+124,784
| +103% | +$4.07M |
|
|
NTRI
459
DELISTED
NutriSystem, Inc.
NTRI
| $8.87M | 0.02% |
328,980
+33,871
| +11% | +$1.35M |
|
460
CGI
GIB
$15.5B
| $8.81M | 0.02% |
152,831
-449,169
| -75% | -$25.5M |
|
461
Marten Transport
MRTN
$1.22B
| $8.78M | 0.02% |
577,614
+361,597
| +167% | +$5.37M |
|
462
BGC Group
BGC
$4.89B
| $8.77M | 0.02% |
1,013,860
+859,759
| +558% | +$7.74M |
|
463
Ryder
R
$10.1B
| $8.74M | 0.02% |
120,100
+81,100
| +208% | +$6.53M |
|
464
Workiva
WK
$3.54B
| $8.68M | 0.02% |
366,060
+166,942
| +84% | +$3.84M |
|
465
Dave & Buster's
PLAY
$357M
| $8.6M | 0.02% |
+205,959
| New | +$9.5M |
|
466
SFL Corp
SFL
$1.61B
| $8.57M | 0.02% |
599,557
-75,389
| -11% | -$1.13M |
|
|
WW
467
DELISTED
WW International
WW
| $8.55M | 0.02% |
134,196
+2,134
| +2% | +$137K |
|
468
Ericsson
ERIC
$33.3B
| $8.55M | 0.02% |
1,335,369
+496,826
| +59% | +$3.34M |
|
469
MKS Inc
MKSI
$20.6B
| $8.54M | 0.02% |
73,827
-51,398
| -41% | -$5.64M |
|
470
Tenaris
TS
$26.8B
| $8.52M | 0.02% |
+245,701
| New | +$8.44M |
|
471
MDU Resources
MDU
$4.32B
| $8.47M | 0.02% |
790,909
-2,860,678
| -78% | -$29M |
|
472
Casella Waste Systems
CWST
$5.69B
| $8.47M | 0.02% |
362,158
-75,924
| -17% | -$1.86M |
|
|
ALTR
473
DELISTED
Altair Engineering Inc
ALTR
| $8.46M | 0.02% |
269,930
+243,929
| +938% | +$6.64M |
|
474
Kinder Morgan
KMI
$68.7B
| $8.46M | 0.02% |
561,700
+314,100
| +127% | +$5.44M |
|
475
SK Telecom
SKM
$13.2B
| $8.44M | 0.02% |
211,879
-954,516
| -82% | -$40.4M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.